Vector Capital buys more Pharsight shares ahead of merger with Tripos

By Lisa Kerner

Charlotte, N.C., Oct. 15 - Pharsight Corp. investors led by Vector Capital Partners III, LLC bought 115,800 additional shares between Oct. 9 and Oct. 14 at prices from $5.1654 to $5.2759 each, it was reported in a schedule 13D/A filed with the Securities and Exchange Commission.

Vector, now with a 34.5% stake in Pharsight, owns Tripos, Inc.

Tripos agreed to acquire Pharsight, a Mountain View, Calif., pharmaceutical software company, for $5.50 per share, or $57 million in cash, it was previously reported.

Pharsight shareholders are set to vote on the merger at a special meeting Oct. 27.

Tripos provides drug discovery informatics products and services. The company is located in St. Louis.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.